ClinicalTrials.Veeva

Menu

Development of a Rapid and Accurate Diagnostic Assay for Tuberculosis

A

Asan Medical Center

Status

Unknown

Conditions

Tuberculosis

Study type

Observational

Funder types

Other

Identifiers

NCT03423550
2018-0020 (Other Identifier)

Details and patient eligibility

About

This study evaluates new technique for diagnosis of tuberculosis. Among patients who are suspected with tuberculosis, participants will be tested conventional method including Xpert TB/RIF assay, and new diagnostic technique using homobifunctionalImidoesters compounds.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who are suspected with pulmonary tuberculosis, tuberculosis meningitis, tuberculosis peritonitis, tuberculosis pleurisy

Exclusion criteria

  • Under 18 years

Trial design

300 participants in 1 patient group

Participants who are suspected with TB

Trial contacts and locations

1

Loading...

Central trial contact

Seiwon Lee

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems